menu
    • menu

    Company profile for Edison Oncology

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Edison Oncology was founded in 2018 by experienced life science industry veterans to develop and commercialize new therapies targeting the fight against cancer. At Edison Oncology, we work with our collaborators to develop a deep understanding of cancer biology in order to identify drug candidates able to overcome treatment resistance and improve survival outcomes and quality of life for cancer patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Edison OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3475 Edison Way Suite R Menlo Park, CA 94025
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.edisononcology.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Edison Oncology Unveils Data On EO1001 And EO?4426
    Edison Oncology Unveils Data On EO1001 And EO?4426

    24 Nov 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/edison-oncology-presents-new-clinical-and-preclinical-data-for-eo1001-in-erbb%e2%80%91driven-1106133

    ACCESSWIRE
    24 Nov 2025
    Share Share
    Edison Oncology Present 2 Posters At AACR-NCI-EORTC Conference
    Edison Oncology Present 2 Posters At AACR-NCI-EORTC Conference

    27 Oct 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/edison-oncology-presents-two-posters-at-the-2025-aacr-nci-eortc-international-confere-1091939

    ACCESSWIRE
    27 Oct 2025
    Share Share
    Edison Reports Promising Interim Data from Ongoing Orotecan® Clinical Trial
    Edison Reports Promising Interim Data from Ongoing Orotecan® Clinical Trial

    08 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edison-oncology-reports-promising-interim-data-from-ongoing-orotecan-clinical-trial-for-recurrent-pediatric-cancers-302110518.html

    PR NEWSWIRE
    08 Apr 2024
    Share Share
    Edison Oncology Announces Presentation of Two Scientific Posters at AACR Meeting
    Edison Oncology Announces Presentation of Two Scientific Posters at AACR Meeting

    20 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edison-oncology-announces-presentation-of-two-scientific-posters-at-aacr-annual-meeting-301803139.html

    PR NEWSWIRE
    20 Apr 2023
    Share Share
    Edison Oncology Partners DNA-damage Response Inhibitor Program with Rakovina
    Edison Oncology Partners DNA-damage Response Inhibitor Program with Rakovina

    31 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/edison-oncology-partners-dna-damage-response-inhibitor-program-with-rakovina-therapeutics-301260035.html

    PRNEWSWIRE
    31 Mar 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search